Long-term safety of lumacaftor–ivacaftor in children aged 2–5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study:

Jordana E Hoppe, MD Mark Chilvers, MD Prof Felix Ratjen, MD John J McNamara, MD Caroline A Owen, MD Simon Tian, MD et al.

6 May, 2021

NZ Respiratory Research Review Issue 191

Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial:

Gunn Marit Traaen, Lars Aakerøy, Tove-Elizabeth Hunt, Britt Øverland, Christina Bendz, Lars Øivind Sande, Svend Aakhus, Morten Wang Fagerland, Sigurd Steinshamn, Ole-Gunnar Anfinsen, Richard John Massey, Kaspar Broch, Thor Ueland, Harriet Akre, Jan Pål Loennechen and Lars Gullestad

5 May, 2021

NZ Respiratory Research Review Issue 197

A low exhaled nitric oxide level excludes a short-term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo-controlled trial:

Lissa Sutherland, Karen Shaw, Clair Parrish, Nicola Singleton, Tricia M. McKeever, Iain Stewart, Dominick Shaw, Matthew J. Martin, Tim Harrison

3 May, 2021

NZ Respiratory Research Review Issue 188

Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease:

Yet H. Khor, MBBS, PhD Lawrence Gutman, MD Nebal Abu Hussein, MD Kerri A. Johannson, MD Ian N. Glaspole, MBBS, PhD Sabina A. Guler, MD Manuela Funke-Chambour, MD Thomas Geiser, MD Nicole S.L. Goh, MBBS, PhD Christopher J. Ryerson, MD

23 April, 2021

NZ Respiratory Research Review Issue 201

Adverse Events Associated With the Addition of Aspirin to Direct Oral Anticoagulant Therapy Without a Clear Indication:

Jordan K. Schaefer, MD; Josh Errickson, PhD; Yun Li, PhD; Xiaowen Kong, MA; Tina Alexandris-Souphis, RN; Mona A. Ali, PharmD; Deborah Decamillo, RN, BSN; Brian Haymart, RN, MS; Scott Kaatz, DO, MSc; Eva Kline-Rogers, RN, MS; Jay H. Kozlowski, MD; Gregory D. Krol, MD; Sahana R. Shankar; Suman L. Sood, MD, MSCE; James B. Froehlich, MD, MPH; Geoffrey D. Barnes, MD, MSc

19 April, 2021

NZ Respiratory Research Review Issue 190

Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study:

Mohammed A. Malik Farooqi, Sachi O'Hoski, Sarah Goodwin, Nima Makhdami, Afia Aziz, Gerard Cox, Joshua Wald, Christopher J. Ryerson, Marla K. Beauchamp, Nathan Hambly, Martin Kolb

19 April, 2021

NZ Respiratory Research Review Issue 201

A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension:

Anna R. Hemnes, MD Luke G. Silverman-Lloyd, BS Shi Huang, PhD Grant MacKinnon, BS Jeffrey Annis, PhD Carolyn S. Whitmore, MSW Ravinder Mallugari, MBBS Rashundra N. Oggs, NP Rezzan Hekmat, BS Rongzi Shan, MD Pauline P. Huynh, BA Chang Yu, PhD Seth S. Martin, MD, MHS Michael J. Blaha, MD, MPH Evan L. Brittain, MD

16 April, 2021

NZ Respiratory Research Review Issue 190

Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer:

Moom R. Roosan, PharmD, PhD Isa Mambetsariev, BA Rebecca Pharaon, BA Jeremy Fricke, BS Hatim Husain, MD Karen L. Reckamp, MD Marianna Koczywas, MD Erminia Massarelli, MD, PhD Andrea H. Bild, PhD Ravi Salgia, MD, PhD

16 April, 2021

NZ Respiratory Research Review Issue 193

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial:

Joseph K Han, MD Prof Claus Bachert, PhD Prof Wytske Fokkens, PhD Prof Martin Desrosiers, MD Prof Martin Wagenmann, MD Stella E Lee, MD et al.

16 April, 2021

NZ Respiratory Research Review Issue 194

Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening :

Yeon Wook Kim, Byoung Soo Kwon, Sung Yoon Lim, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Kyung Won Lee, Jae Ho Lee, Jin-Haeng Chung, Eunjeong Ji, Choon-Taek Lee,

15 April, 2021

NZ Respiratory Research Review Issue 193